DSM acquires Microbia, Inc. to expand its leading position in specialty ingredients

24-Sep-2010 - Netherlands

Royal DSM N.V announced the acquisition of Microbia, Inc.from Ironwood Pharmaceuticals, Inc. The terms of the acquisition will not be disclosed.

Microbia is a industrial biotechnology research and development specialist. It has developed a highly effective technology platform that enables it to produce high-quality, natural carotenoids (including beta-carotene and canthaxanthin), nutritional products and other specialty materials and chemicals from renewable resources.

Microbia’s sales are still limited. The acquisition will allow DSM to incorporate Microbia’s proprietary platform and world class research and development capabilities and support DSM’s ongoing development of the natural carotenoids market.

Leendert Staal, President and CEO of DSM Nutritional Products commented: “The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes. This acquisition allows us to expand our product portfolio as well as our research and development capabilities.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances